According to the SEC Form 4 filings, Harrington Michael J, being in a position of
No biography is available at this moment.
Buys | $109,100 | 1 | 100 |
Sells | $0 | 0 | 0 |
| 2026-08-12 | Elanco Animal Health Incorporated ELAN | director | 5,000 0.001% | $21.82 | $109,100 | +3.68% | ||
| 2024-08-22 | Elanco Animal Health Incorporated ELAN | director | 3,500 0.0007% | $14.85 | $51,974 | -11.91% | ||
| 2024-03-08 | Elanco Animal Health Incorporated ELAN | director | 3,100 0.0006% | $16.29 | $50,494 | -17.75% | ||
| 2021-11-30 | Elanco Animal Health Incorporated ELAN | director | 5,000 0.001% | $29.25 | $146,245 | -19.26% | ||
| 2021-08-11 | Elanco Animal Health Incorporated ELAN | director | 6,000 0.0012% | $28.98 | $173,910 | -8.25% | ||
| 2020-03-09 | Elanco Animal Health Incorporated ELAN | director | 8,000 0.002% | $23.84 | $190,720 | +14.23% | ||
| 2019-06-03 | Sale | Eli Lilly and Company LLY | Senior VP and General Counsel | 32,000 0.0033% | $116.72 | $3.74M | +1.75% | |
| 2019-04-22 | Elanco Animal Health Incorporated ELAN | director | 7,000 0.0016% | $26.75 | $187,215 | -7.83% | ||
| 2017-06-09 | Sale | Eli Lilly and Company LLY | Senior VP and General Counsel | 45,666 0.0041% | $79.97 | $3.65M | +2.65% |